T1	Participants 108 118	population
T2	Participants 597 607	10,865 men
T3	Participants 304 342	prostate-specific antigen levels (PSA)
T4	Participants 650 658	1202 men
T5	Participants 1200 1261	1202 men studied, 361 cases of prostate cancer were diagnosed
